Stereotactic body radiation therapy in recurrent hepatocellular carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 2, 2012, Pages 355-361

  Huang, Wen Yen ^a   Jen, Yee Min ^a   Lee, Meei Shyuan ^b   Chang, Li Ping ^c   Chen, Chang Ming ^a   Ko, Kai Hsiung ^a   Lin, Kuen Tze ^a   Lin, Jang Chun ^a   Chao, Hsing Lung ^a   Lin, Chun Shu ^a   Su, Yu Fu ^a   Fan, Chao Yueh ^a   Chang, Yao Wen ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Cyberknife; Radiotherapy; Recurrent hepatocellular carcinoma; Stereotactic body radiation therapy

Indexed keywords

ACUTE TOXICITY; CONTROL GROUPS; CYBERKNIFE; DOSE FRACTIONATION; FAILURE-FREE RATES; HEPATOCELLULAR CARCINOMA; IN-FIELD; MULTIVARIABLE ANALYSIS; OVERALL SURVIVAL RATES; PROGNOSTIC FACTORS; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TUMOR SIZE;

ONCOLOGY; RADIOLOGY;

RADIOTHERAPY;

SORAFENIB; THALIDOMIDE;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER FATIGUE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CHEMOEMBOLIZATION; CONTROLLED STUDY; FAILURE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; STEREOTACTIC BODY RADIATION THERAPY; STOMACH ULCER; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FIDUCIAL MARKERS; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY, IMAGE-GUIDED; SURVIVAL RATE; TUMOR BURDEN;

EID: 84865663687     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.058     Document Type: Article

References (20)

1. D. Choi, H.K. Lim, and H. Rhim Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: Long-term results and prognostic factors Ann Surg Oncol 14 2007 2319 2329
2. M.D. Lu, X.Y. Yin, and X.Y. Xie Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy Br J Surg 92 2005 1393 1398
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429 442
4. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial Lancet 359 2002 1734 1739
5. A.J. Wigg, K. Palumbo, and D.R. Wigg Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use J Gastroenterol Hepatol 25 2010 664 671
6. B.O. Choi, I.B. Choi, and H.S. Jang Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis BMC Cancer 8 2008 351
7. B.O. Choi, H.S. Jang, and K.M. Kang Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma Jpn J Clin Oncol 36 2006 154 158
8. A. Mendez Romero, W. Wunderink, and S.M. Hussain Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study Acta Oncol 45 2006 831 837
9. R.V. Tse, M. Hawkins, and G. Lockwood Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664
10. C. Louis, S. Dewas, and X. Mirabel Stereotactic radiotherapy of hepatocellular carcinoma: Preliminary results Technol Cancer Res Treat 9 2010 479 487
11. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
12. W. Yang, M.H. Chen, and S.S. Yin Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: Therapeutic efficacy on early and late-phase recurrence AJR Am J Roentgenol 186 2006 S275 S283
13. Y. Zhou, C. Sui, and B. Li Repeat hepatectomy for recurrent hepatocellular carcinoma: A local experience and a systematic review World J Surg Oncol 8 2010 55
14. N. Kothary, J.J. Heit, and J.D. Louie Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy J Vasc Interv Radiol 20 2009 235 239
15. E. Sotiropoulou, I. Stathochristopoulou, and K. Stathopoulos CT-guided fiducial placement for Cyberknife stereotactic radiosurgery: An initial experience Cardiovasc Intervent Radiol 33 2010 586 589
16. T.T. Cheung, K.K. Ng, and R.T. Poon Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma J Hepatobiliary Pancreat Surg 16 2009 655 660
17. H. Kasugai, Y. Osaki, and H. Oka Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: An analysis of 3,891 ablations in 2,614 patients Oncology 72 2007 72 75
18. T. Livraghi, L. Solbiati, and M.F. Meloni Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study Radiology 226 2003 441 451
19. C. Bouza, T. Lopez-Cuadrado, and R. Alcazar Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma BMC Gastroenterol 9 2009 31
20. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25